MFDS — authorised 27 December 1985
- Marketing authorisation holder: FOUGERA PHARMS
- Status: likely_approved
🇰🇷 Temovate in South Korea
MFDS authorised Temovate on 27 December 1985
Marketing authorisation
Temovate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Temovate approved in South Korea?
Yes. MFDS authorised it on 27 December 1985.
Who is the marketing authorisation holder for Temovate in South Korea?
FOUGERA PHARMS holds the South Korean marketing authorisation.